Hims & Hers – The US telemedicine provider rides on a narrow FDA recommendation!

An 8-to-6 recommendation is not an approval. FDA advisors are opening peptides like BPC-157 for pharmacy compounding, but the agency must first initiate a formal process – and its own scientists are against it. Hims has already purchased the factory, but revenue would not come until at least 2027. Both analyst targets are below the current price: the fantasy is priced in, the risk is not. Eight to six votes Eight yes votes against six no votes with one abstention. With this razor-thin majority, an advisory committee to the US Food and Drug...